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Simple Summary: The exposure of cancer cells to cadmium compounds may be associated with
the acceleration of tumor progression. It is known that cadmium is a transcriptional regulator,
and the study of differentially expressed genes has enabled the identification and classification of
cadmium-associated molecular signatures as useful biomarkers that are potentially transferable to
clinical research. This review recapitulates the studies that report the detection of such signatures in
breast, gastric, colon, liver, lung, and nasopharyngeal tumor cell models, as specifically demonstrated
by individual gene or whole genome expression profiling.
Abstract: The exposure of cancer cells to cadmium and its compounds is often associated with
the development of more malignant phenotypes, thereby contributing to the acceleration of tumor
progression. It is known that cadmium is a transcriptional regulator that induces molecular repro-
gramming, and therefore the study of differentially expressed genes has enabled the identification
and classification of molecular signatures inherent in human neoplastic cells upon cadmium exposure
as useful biomarkers that are potentially transferable to clinical research. This review recapitulates
selected studies that report the detection of cadmium-associated signatures in breast, gastric, colon,
liver, lung, and nasopharyngeal tumor cell models, as specifically demonstrated by individual gene
or whole genome expression profiling. Where available, the molecular, biochemical, and/or physio-
logical aspects associated with the targeted gene activation or silencing in the discussed cell models
are also outlined.
Keywords: cadmium; differential expression; gene signature; in vitro cell models; breast cancer;
gastric cancer; colon cancer; liver cancer; lung cancer; nasopharyngeal cancer
1. Introduction: A Short Excursus on Cadmium and Eukaryotic Cell Systems
Cadmium (Cd) is an underground mineral extracted as part of zinc deposits which,
along with its compounds, exhibits a broad range of applications in the industry spanning
from battery components to stabilizers for plastics, electroplated coatings for non-ferrous
metals and dye pigments. Volcanic eruption and the erosion of Cd-containing rocks
represent the major natural sources of the metal; on the other hand, humans are mainly
exposed to Cd via cigarette smoking and, to a lesser extent, food ingestion, inhalation of
polluted air, and the ingestion of contaminated drinking water [1].
Cd is not essential for the human body and does not exert any useful cellular metabolic
effect. The cellular uptake of free Cd ions and complexes of Cd with small organic molecules
involves various ion channels, carriers, and ATPase pumps, whereas Cd-protein complexes
are internalized via receptor-mediated endocytosis, as extensively reviewed by the authors
in [2]. Once accumulated in the intracellular milieu, the metal may interact with the thiol
groups of cysteines present in cellular proteins, thus inducing an impairment of the func-
tions of the enzymes located in different cellular compartments. The numerous biological
targets and complex mechanisms of the action of Cd ions have been explored in depth
in previously-published reviews [3–5]. It is known that Cd can cause mitochondrial dys-
function, exert genotoxic and epigenotoxic effects, and can also interfere with a number of
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cell proliferation-linked signalization pathways. Reports in the literature have shown that
mitochondria are one of the main intracellular targets for Cd toxicity due to the blocking of
the electron transfer chain at complex III, which is considered the principal site for the pro-
duction of reactive oxygen species (ROS), thereby favoring the over-production of the latter
at the expense of ATP. This leads to a dissipation of mitochondrial transmembrane potential
with a consequent alteration of not only the cell’s redox status but also mitochondrial and
nuclear gene expression and the genome integrity [6,7]. In fact, it is widely acknowledged
that the genome-related effects of Cd are based upon its ability to damage the antioxidant
defense and DNA repair systems, and also due to the replacement of zinc by Cd in p53
with a consequent impairment of protein activity, thereby triggering the occurrence of
DNA strand breaks and chromosomal aberrations [8,9]. The inhibition of p53, coupled
with the direct stimulation of mitogenic signals via calcium and inositol triphosphate
second messengers, is also responsible for Cd-dependent enhanced cell proliferation. On
the other hand, in specific cell systems the metal was conversely found to induce endo-
plasmic reticulum stress due to severe ROS and calcium signaling, which ultimately leads
to apoptotic and/or autophagic cell death [10–13]. As a further DNA-directed activity,
evidence has been produced that Cd may be regarded as an epigenetic modulator, given
its ability to alter the global DNA methylation pattern via the down-regulation of DNA
methyltransferase activity and demethylation which, upon prolonged exposure, turns into
enhanced enzyme activity and genome hypermethylation. These opposite alterations may
result in the up-regulation of cellular protooncogenes and the silencing of oncosuppressor
genes, respectively [14,15].
Evidence collected in the literature has highlighted that the exposure of cancer cells to
Cd compounds may be associated with the development of more malignant phenotypes,
thereby contributing not only to the onset of cell transformation in the tumor initiation
stage, which has been widely reviewed in several articles e.g., in [16,17], but also to the
acceleration of tumor progression. An example of this aspect is the growth-promoting
“metalloestrogen” role played by Cd on estrogen receptor α-positive breast cancer cells.
On the other hand, based upon the intrinsic cytospecificity, Cd has been proven to act
as a two-edged sword, conversely down-regulating viability and causing the death of
a number of tumor cell lines, such as those derived from triple-negative breast cancer
and hepatocarcinoma [18–20]. Cd is a transcriptional regulator that induces molecular
reprogramming [21]; therefore, the study of differentially expressed genes has enabled
the identification and classification of the molecular signatures inherent in human neo-
plastic cells upon Cd exposure as useful biomarkers that are potentially transferable to
clinical research. The goal of this review is to recapitulate selected studies that report the
detection of such signatures, as specifically demonstrated by individual gene or whole
genome expression profiling, in particular focusing on breast, gastric, colon, liver, lung
and nasopharyngeal tumor cell models. Where available, the molecular, biochemical
and/or physiological aspects associated with the targeted gene activation or silencing in
the discussed cell models will be also briefly outlined.
2. Molecular Signatures in Breast Cancer Cells
The search for Cd exposure-associated molecular signatures has been conducted in
two cell lines, i.e., MDA-MB231 and MCF-7. The former was established from a pleural
effusion of a triple-negative breast cancer (TNBC) of basal morphology, which was negative
for estrogen receptor (ER) α and progesterone receptor (PR) expression and its p53 was
inactivated by a mutation in codon 280 of exon 8. The ERα-positive and PR-negative MCF-7
cell line was established from a pleural effusion of a highly hormone-responsive malignant
adenocarcinoma [22–24].
2.1. Molecular Signatures in MDA-MB231 Cells
Concerning TNBC cells, about a decade ago papers published by my group of re-
searchers first contributed to this issue by investigating the effect of administering different
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concentrations of CdCl2 to MDA-MB231 cells and also comparing the tumor cell behavior
with that of HB2 cells, a nonneoplastic immortalized line from the human breast epithe-
lium [25]. The obtained results demonstrated the cytotoxic effect of the molecule with
a 50% inhibitory concentration (IC50) at 96 h of 5 µM, which conversely was ineffective
in modifying the survival and growth of HB2 cells [18]. Among the biological aspects
of MDA-MB231 cells studied under this experimental condition, molecular signatures
were searched that demonstrated an up- or down-regulation of the expression levels of
genes coding for heat shock proteins (hsp), metallothioneins (MT), cytochrome oxidase
subunits, and other factors related to apoptosis, signal transduction, and growth control,
as summarized sinoptically in Table 1 (see refs. [18,26–30]).
Table 1. Gene expression changes in MDA-MB231 breast cancer cells exposed to 5mM CdCl2 for 96 h.
Gene Protein Product Up↑ Down↓ Fold Changes
HSPA5 Endoplasmic reticulum chaperone BiP ↓ 54.2
HSPA8 Heat shock cognate 71 kDa protein ↓ 4.9
HSPB1 Heat shock protein β-1 ↑ 8.7
HSPD1 60 kDa heat shock protein, mitochondrial ↓ 2
HSP90AB1 Heat shock protein HSP 90-β ↓ 2.57
TRAP1 Heat shock protein 75 kDa, mitochondrial ↓ 9.5
MT1A Metallothionein-1A ↑ 2.34
MT1F Metallothionein-1F ↑ 3.65
MT1G Metallothionein-1G ↓ 18.8
COX2 Cytochrome c oxidase subunit 2 ↓ 3
COX4 Cytochrome c oxidase subunit 4 ↓ 1.9
BCL2 Bcl-2 ↓ 53
WAF1 Cyclin-dependent kinase inhibitor 1 ↑ 10.4
DAPK Death-associated protein kinase-1 ↑ 55
RIPK1 Receptor-interacting protein 1 ↑ undetectable incontrol
CASP1 Caspase-1 ↑ 106
CASP2 Caspase-2 ↑ 3
CASP6 Caspase-6 ↑ 31.3
CASP7 Caspase-7 ↑ 15
CASP8 Caspase-8 ↑ 9.25
CASP9 Caspase-9 ↑ 4.7
MAPK14 Mitogen-activated protein kinase p38 α ↓ 8
MAPK11 Mitogen-activated protein kinase p38 β ↓ 4
MAPK12 Mitogen-activated protein kinase p38 γ ↑ 7
AEG1 Astrocyte elevated gene-1 protein ↓ 8.5
PLP2 Proteolipid protein 2 ↑ 2
FOS Proto-oncogene c-Fos ↓ 3.2
JUN Proto-oncogene c-Jun ↓ 3.5
In light of the literature on the subject, some of the produced data allow for the
following comments to be made.
2.1.1. Expression Levels of MTs
MTs are a group of cysteine-rich, low molecular weight proteins able to bind metals
and act as controllers of cellular homeostasis through protection against oxidative stress,
heavy metal toxicity, and DNA damages. The exposure of MDA-MB231 cells to CdCl2
resulted in the up-regulation of MTIA and MTIF whilst MTIG was down-regulated. It is
noteworthy that MTIA mRNA and proteins were proven to be induced by the exposure of
human proximal tubule cells to Cd concentrations, eliciting a downfall of cell viability [31].
In addition, MTIA overexpression provided HEK293 embryonic kidney cells with more
resistance to the Cd administration than other MT isoforms [32]. Taking the data from
the literature into account, it is conceivable that the up-regulation of this MT isoform in
the MDA-MB231 cells may represent a cellular defense reaction specifically set up against
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Cd intoxication. Interestingly, Chang et al. [33] validated MTIA mRNA expression as a
molecular marker for renal dysfunction in occupational Cd exposure. Concerning the other
two MTs, Albrecht et al. [34] reported a significant increase in the MT1F transcripts in
RWPE-1 human prostate epithelial cells at the time points immediately preceding cell death
due to exposure to 3, 6 and 12 mM Cd2+ over a 13-day period, which may be consistent with
the cytotoxic effect exerted on MDA-MB231 cells. Moreover, the down-regulation of MTIG,
whose reduction was found to induce glutathione depletion and lipid peroxidation in
hepatocellular carcinoma cells [35], may be a contributing factor to MDA-MB231 cell death.
2.1.2. Expression Levels of Heat Shock Proteins
The up-regulation of HSPB1 and the down-regulation of HSPA5, HSPD1, HSP90AB1
and TRAP1 in CdCl2-treated MDA-MB231 cells has been demonstrated. It is known that
oxidative damage and ROS generation may selectively trigger a significant decrease in the
HSPA5 levels [36] and therefore these data are consistent with the findings of a study into
the increase in mitochondrial respiratory activity and the accumulation of ROS in treated
MDA-MB231 cells, as shown by Cannino et al. [27]. Moreover, the down-regulation of
HSPD1 and TRAP1, coding for two mitochondrial chaperonins, could be responsible for the
accumulation of ROS as reported by the authors in [37,38], whereas the down-regulation
of HSPA8 may contribute to the decrease in cell protection against ROS-mediated lipid
peroxidation during the oxidative challenge. Interestingly, Masuda et al. [39] suggested
that Bcl-2 may be one of the regulators of TRAP1 expression, which is consistent with
the data demonstrating the concomitant down-regulation of BCL2 and TRAP1 in exposed
MDA-MB231 cells. Exposure to 10 mM CdCl2 for 24 h was found to be responsible for the
decrease in the expression level of HSP90AB1, contributing to the metal-promoted lethal
effect on cholinergic neurons [40]. Kindas-Mugge et al. [41] demonstrated the decrease in
the proliferation rate of HSBP1-overexpressing MDA-MB231 cells. It is conceivable that
the restraining effect of hsp27, the product of HSBP1, on cell growth behavior could be
jointly responsible with the induction of cell death for the halving of the MDA-MB231 cell
numbers observed after 96 h-treatment with 5 µM CdCl2.
2.1.3. Expression Levels of Cytochrome Oxidase Components
The exposure of MDA-MB231 cells to CdCl2 resulted in the down-regulation of COX2
and COX4, thereby suggesting a relationship between the reduction in the amount of COX
and the production of ROS, given that mitochondrial proteins are some of the earliest
cellular targets because of their immediate proximity to the ROS-generating sources [27].
2.1.4. Expression Levels of Proliferation- and Apoptosis-Related Genes
The exposure of MDA-MB231 cells to CdCl2 determined the down-regulation of BCL2
and AEG1 and the up-regulation of DAPK, WAF1, RIPK, PLP2, FOS, JUN, and several
genes coding for caspases, the enzymatic components of the apoptotic machinery. This
result suggests that the metal directs the tumor cells towards a type of death which shares
several features with programmed cell death. In fact, the Bcl-2 protein is an apoptosis-
suppressor factor, whereas death-associated protein kinase-1 is involved in the onset of
the death pathways of apoptosis, as well as autophagy and programmed necrosis. In
MDA-MB231 cells, cyclin-dependent kinase inhibitor 1 was proven to negatively modulate
the cell cycle progression due to binding to both the cyclin–CDK complex and proliferating
the cell nuclear antigen, and the RIPK1 product, a kinase forming part of the tumor
necrosis factor receptor-1 (TNFR1) complex I, which is known to be one of the most
important upstream mediators of NF-κB signaling as well as an important regulator of
cell death [42–44]. In breast cancer, the astrocyte elevated gene-1 protein was found to be
an agonist of the Wnt pathway which regulates cell proliferation and is involved in the
control of the NF-kB pathway and the expression of proliferation-promoting FOS/JUN
genes [29,45]. The knockdown of endogenous AEG1 was proven to sensitize MDA-MB-231
cells to TRAIL-induced apoptosis both in vitro and in vivo. Therefore, in line with the
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data of Zhang et al. [46], the possibility that CdCl2-mediated AEG1 down-regulation may
facilitate the intrinsic and extrinsic apoptosis pathways via the decrease in BCL2 expression
levels and CASP8 up-regulation could be considered. In addition, PLP2 over-expression
was also found to be correlated with the increase in CASP8 expression levels [30].
2.1.5. Expression Levels of MAPKs
CdCl2 treatment on MDA-MB231 cells was efficient in decreasing the expression levels
of MAPK11 and −14 and increasing that of MAPK12, although an opposite variation in
the accumulation of the protein product of the latter, i.e., mitogen-activated protein kinase
p38γ was recorded. Zhong et al. [47] demonstrated that in case of oxidative stress, the
activation of the MAPK11/12/13/14/NF-kB pathway may induce protective autophagy
via the transcriptional activation of the autophagy-related genes MAP1LC3B, BAG3, and
HSPA1A in HeLa cells treated with an anticancer copper complex. Therefore, it might
be assumed that MAPK down-regulation following the exposure of breast cancer cells to
CdCl2 may contribute to the cytotoxic effect through the inhibition of such a protective
cell response.
More recently, additional Cd-related molecular signatures in MDA-MB231 cells have
been brought to light. Wei et al. [48,49] reported that non-cytotoxic concentrations of
CdCl2 (0.5–1 µM) trigger cell migration, an ability which in vivo can result in an enhanced
metastatic attitude during TNBC progression. Using luciferase reporter assays, after
prolonged Cd treatment (3 µM for 4 weeks), they demonstrated the up-regulation of the
transcriptional activity of the T-cell factor/lymphoid enhancer-binding factor (TCF/LEF),
whose contribution to the Wnt signaling machinery is well-known, and Snail, a target
of the Notch1 pathway primarily involved in epithelial-mesenchymal transition (EMT)
processes as demonstrated by knockdown experiments [50,51]. The effect on the TCF/LEF
appeared to be due to Cd-induced signaling via the interaction with the integrin/focal
adhesion kinase (FAK) pathway leading to the inhibition of GSK3β and consequent β-
catenin accumulation and nuclear translocation. On the other hand, Cd induced the
elevation of Snail transcription by up-regulating the activity of its promoter. Moreover,
their results also suggested that Cd may inhibit miR-200 that post-transcriptionally restrains
the translation of ZEB-1 which, in turn, is a direct suppressor of the transcription of the
gene encoding the epithelial marker E-cadherin, thus further contributing to the regulation
of EMT [52].
2.2. Molecular Signatures in MCF-7 Cells
Concerning the ERα-positive MCF-7 cell line, in 2013 Lubovac-Pilav et al. [53] investi-
gated the effect of chronic (up to 6 months) 10−7 M CdCl2 exposure on the gene expression
pattern by high throughput microarray technology followed by hierarchical clustering
analysis and functional annotations. More recently, Liang et al. [54] complemented the
analysis by producing data on the epigenomic as well as the transcriptomic profiles in-
duced by short-term (72 h) 60 µM CdCl2 treatment, further identifying also in this case the
critical pathways and genes via bioinformatic studies. Their cumulative results provide a
broad picture of the impact of the exposure of breast cancer cells to the metal compound at
the gene signature level, with 795 differentially expressed genes identified by the authors
in [53] and 997 differentially expressed genes identified by the authors in [54]. In particular,
taking their most significant findings on the highest changes in gene expression levels and
the data from the literature into account, the following comments can be made.
2.2.1. Expression Levels of Breast Cancer-Associated Factors
Ninety-seven genes identified by the authors in [53] were known to be breast cancer-
associated, thereby confirming that Cd is active in accelerating breast carcinogenesis
by modulating the expression of genes involved in tumor progression. Table 2 shows
those breast carcinogenesis-associated genes positioned among the top 30 up- and down-
regulated ones upon chronic metal exposure, all of which were also linked to endocrine
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disruption effects, while some of them were also linked to the regulation of cell prolifera-
tion and differentiation (e.g., CRABP1 and CCNE1) and ROS production (e.g., UCP2). The
identification of gene signatures that were significantly regulated by short-term CdCl2
exposure and strongly associated to breast carcinogenesis through the protein-protein
network analysis led Liang et al. [54] to extract TXNRD1 and CCT3 from the list of 400 vali-
dated genes as those endowed with the highest degree of expression change, hazard ratio
difference, and degree of connectivity. The first gene codes for thioredoxin reductase 1, an
intracellular redox sensor and antioxidant enzyme whose deregulation may be involved in
breast cancer initiation [55]. CCT3 protein product is the chaperonin containing TCP1 sub-
unit 3, a component of a complex which catalyses the correct folding of proteins involved in
cytoskeletal assembly and the cell cycle and whose involvement in the promotion of breast
cancer cell proliferation and metastasis via Wnt has been recently acknowledged [56,57]. It
is also of note that one of the most significant Gene Ontology (GO) terms in which a large
amount of the genes validated by Liang et al. [54] were enriched was the “Wnt signaling
pathway”, which is known to be highly dysregulated in breast tumor [58].
Table 2. Breast carcinogenesis-associated gene signatures in MCF-7 cells submitted to chronic CdCl2
exposure [53].
Gene Protein Product Up↑ Down↓
ANXA3 Annexin A3 ↑
CCNE1 Cyclin E1 ↑
CRABP1 Cellular retinoic acid-binding protein ↑
DKK1 Dickkopf-related protein 1 ↑
MT2A Metallothionein 2A ↑
PDLIM1 PDZ and LIM domain protein 1 ↑
SRD5A1 3-oxo-5-alpha-steroid 4-dehydrogenase 1 ↑
UCP2 Mitochondrial uncoupling protein 2 ↑
PGK1 Phosphoglycerate kinase 1 ↓
TK1 Thymidine kinase, cytosolic ↓
2.2.2. Expression Levels of Metal Ion- and Xenobiotic-Binding Factors
The chronic exposure of MCF-7 cells to CdCl2 was proven to affect the expression level
of the genes coding for not only Cd- but also calcium-, zinc- and iron-binding proteins due
to the mimesis and interference played by Cd towards the other metals. Table 3 shows those
genes positioned among the top 30 up- and down-regulated ones in the “GO molecular
functions: metal ions” category. More specifically, one of them was subcategorized as “cad-
mium ion binding” (MT1F), five were subcategorized as “calcium ion binding” (ANXA3,
ANXA2P2, ATP2A3, FKBP9 and OCM), one was subcategorized as both (MT1X), and four
were subcategorized as “zinc ion binding” (CBFA2T3, MT2A, PDLIM1 and ZNHIT2). This
was consistent with the ability of Cd to mimic other divalent cations thus stimulating the
expression of metal transporters. The up-regulation of MT1 expression after the short-term
exposure of MCF-7 cells to Cd was also reported by Darwish et al. [59] who also demon-
strated the concurrent over-expression of MDR1 and MRP2 genes, coding for the xenobiotic
transporters multidrug resistance-associated protein 1 and 2, respectively, which are known
to also be involved in Cd efflux as a cytoprotective reaction to cell intoxication [60].
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Table 3. Metal ion binding-associated gene signatures in the MCF-7 cells submitted to chronic CdCl2
exposure [53].
Gene Protein Product Up↑ Down↓
ANXA3 Annexin A3 ↑
ANXA2P2 Annexin A2 pseudogene 2 ↑
ATP2A3 ATPase, Ca2+ transporting, ubiquitous ↑
CBFA2T3 CBFA2/RUNX1 partner transcriptional co-repressor 3 ↑
FKBP9 FK506-binding protein 9 ↑
MT1F Metallothionein 1F ↑
MT1X Metallothionein 1X ↑
MT2A Metallothionein 2A ↑
PDLIM1 PDZ and LIM domain protein 1 ↑
ZNHIT2 Zinc finger HIT domain-containing protein 2 ↑
OCM Oncomodulin ↓
2.2.3. Expression Levels of Cell Growth-Associated Factors
Another GO category which was analyzed in chronically CdCl2-intoxicated MCF-7
cells was “GO biological process: cell growth” [54]. Two were the genes found among
the top 30 up-regulated ones, that is, cyclin E1-coding CCNE1 which was subcategorized
under the GO terms “cell division” and “cell cycle”, and the zinc ion transporter-coding
CBFA2T3 included in the “cell proliferation” subcategory. It is known that cyclin E1 is an
oncogene which controls the G1/S phase transition and its expression is directly related
to the aggressive potential of breast cancer [61]; on the other hand, the association of
metal treatment on breast tumor cells and CBFA2T3 over-expression is still undetermined.
In addition, consistent with the Cd-induced positive effect on breast tumor cell growth,
Siewit et al. [62] demonstrated the up-regulation of CCND1 and MYC, coding for cyclin
D1 and c-myc proteins, and the down-regulation of CDKN1A, coding for the p21/WAF1
protein, after 24 h of MCF-7 cell exposure to micromolar CdCl2 concentrations.
2.2.4. Expression Levels of Methyltransferases
Following MCF-7 cell treatment with 0.1, 0.5 and 1 mM CdCl2 for 24 h and 48 h,
Ghosh et al. [63] reported the Cd dose-dependent increase in the expression of the PRMT5
and EZH2 genes coding for the proteins arginine methyltransferase 5 and histone-lysine
N-methyltransferase enhancer of zeste homolog 2, respectively, which are two critical
epigenetic modulators responsible for the development of multiple cancer histotypes. The
experimental data collected suggested that such expressional modulations could be due
to CpG island demethylation in the gene promoter sites as a positive feedback loop of
the Cd-induced down-regulation of methyltransferase activity, and/or the Cd-promoted
increase in the levels of NFYA and E2F1 transcription factors and their subsequent enriched
recruitment to the demethylated gene promoters.
2.2.5. Expression Levels of Heat Shock Proteins
The dose-dependent up-regulation of the HSPA2 gene, coding for hsp70 protein, was
reported by Darwish et al. [59] in short-term (24 h) Cd-treated MCF-7 cells (10 and 100 µM
concentrations) and was associated with the role of this molecular chaperone in preventing
protein degradation under stress conditions.
2.2.6. Expression Levels of Antioxidant System and Inflammatory Markers
In the same paper, Darwish et al. [59] demonstrated the drastic dose-dependent down-
regulation of some genes whose products are involved in the protection against oxidative
damage, i.e., glutathione S-transferase omega 1, NAD(P)H quinone dehydrogenase 1,
superoxide dismutase 1 and 2, and catalase, and the up-regulation of HO-1, coding for
the antioxidant heme oxigenase 1 enzyme, which is known to be triggered by Cd in
MCF-7 cells via the p38 kinase pathway and via Nrf2 [64]. Moreover, they found that Cd
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determined a significant dose-dependent accumulation of the mRNAs of cyclooxygenase-2,
the tumor necrosis factor-α, and interleukin 8 and 10, whose induction is conceivably
linked to inflammation and cell damage in various organs. Interestingly, a reduction in
the expression of these genes and a concurrent increase in the expression of the genes
for metallothionein-1 and the xenobiotic transporters was obtained by the co-exposure of
MCF-7 cells with both Cd and fat-soluble vitamins (mainly D, whereas A and E to a lesser
degree). This confirmed the cytoprotective effects of the latter which make them a dietary
supplement worth investigating for people at high risk of exposure to Cd.
3. Molecular Signatures in Cancer Cells of the Gastrointestinal Tract
3.1. Molecular Signatures in Gastric Cancer Cells
The search for Cd exposure-associated molecular signatures has been conducted in
cell lines isolated from gastric adenocarcinoma, i.e., MKN28 (well-differentiated), SNU638
(poorly differentiated with the mutated p53 gene) and AGS, the latter characterized by
gene expressions typical of tumors that likely process from intestinal metaplasia [65,66]. In
these cell lines Khoi et al. [67] examined the effects of a 4 h-treatment with 20 µM Cd on the
expression levels of the PLAUR gene, coding for urokinase-plasminogen activator receptor
(uPAR), demonstrating its time-dependent up-regulation. A more detailed investigation
on the sole Cd-treated AGS cells brought evidence that PLAUR over-expression was to be
ascribed to the activation of the ERK1/2-NFkB-AP1 pathway and that uPAR accumulation
was a likely mediator of Cd-induced stimulation of cell invasiveness.
3.2. Molecular Signatures in Colon Cancer Cells
The search for Cd exposure-associated molecular signatures has been conducted in the
poorly differentiated RKO cell line, which bears mutations in BRAF and PIK3CA oncogenes,
and the HT-29 cell line, isolated from a primary colon adenocarcinoma [68,69].
3.2.1. Molecular Signatures in RKO Cells
The subchronic low-dose exposure of RKO cells to Cd (50 µM for 24 h) [70] resulted
in the differential expression of twenty genes, most of which belong to the hsp-coding
family and are listed in Table 4, that can be considered as potential carcinogenesis-linked
genes under the experimental conditions used. Among the other genes shown to undergo
expression alterations, some were related to the detoxication of chemical carcinogens
(AKR1C2), cell survival (DCD, IDH1), migration-promoting EMT transition (P4HB), and
colon cancer metastasis (PGK1) [71–73].
Table 4. Differentially expressed hsp-coding genes in RKO colon carcinoma cells submitted to
subchronic low-dose CdCl2 exposure [70].
Gene Protein Product
HSP90AA1 Heat shock protein 90 kDa α (cytosolic), class A member 1
HSP90AB1 Heat shock protein 90 kDa α (cytosolic), class B member 1
HSP90B1 Heat shock protein 90 kDa β (Grp94), member 1
HSPA5 Endoplasmic reticulum chaperone BiP
HSPA8 Heat shock cognate 71 kDa protein
HSPA9 Heat shock 70 kDa protein 9 (mortalin)
3.2.2. Molecular Signatures in HT-29 Cells
More recently, dealing with the cyclooxygenase inflammatory pathway, a study by
Naji et al. [74] using the luciferase reporter assay demonstrated the early (6 h) and time-
dependent 100 nM CdCl2-driven increase in COX2 expression at the transcriptional level
in HT-29 colon adenocarcinoma cells. It is widely acknowledged that the cyclooxygenase
pathway is involved in colorectal malignant progression, and also promotes the migration
of tumor cells via the activation of the ROS-p38-COX-2-PGE2 and the ROS-Akt pathways.
Therefore, the up-regulation of the inducible COX-2 isoform may be considered as one of
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the mechanisms by which exposure to environmental Cd pollutants maximizes colorectal
malignancy in exposed individuals. In addition, in cells treated with 0.05–10 µM CdCl2 for
24 h, Iftode et al. [75] reported the suppression of the expression of DNMT1 and DNMT3B
genes, coding for DNA methyltransferase-1 and -3β and which act as hypomethylating
agents likely responsible for the carcinogenetic properties of Cd.
4. Molecular Signatures in Liver Cancer Cells
The search for Cd exposure-associated molecular signatures has been conducted in
HepG2 cells, isolated from a differentiated hepatocellular carcinoma.
Fabbri et al. [76] and Urani et al. [77] performed a whole-genome analysis by cDNA
microarray after 24 h exposure of this cell line to 2 and 10 µM CdCl2, considered to be low
human-relevant metal concentrations. In particular, the work of Urani and coworkers has
also focused on intracellular zinc displacement by Cd and its molecular consequences, as
zinc is an acknowledged second messenger and transcriptional regulator. Their investiga-
tion into gene expression profiling was complemented by a miRNA expression analysis,
due to the considerable involvement of their altered regulation in the carcinogenetic pro-
cess. A group of eleven genes, all belonging to the metallothionein-coding family (i.e.,
MT1A, -B, -E, -F, -G, -H, -JP, -L, -M, -X and -2A) were found up-regulated after exposure
to CdCl2 concentrations whereas the down-regulation of 12 miRNAs and the differential-
expression of 949 genes was proven in response to the treatment with the sole higher
metal concentration. In particular, the down-regulation affected the genes involved in the
liver function pathways (e.g., fatty acid/cholesterol metabolism and hemostasis) while the
up-regulation concerned the genes involved in inflammation and cancer progression (e.g.,
cytokine-cytokine receptor interaction-, focal adhesion- and MAPK signaling). A subset of
relevant genes was further submitted to validate their differential expression through real
time-PCR (Table 5).




COL1A1 Collagen type I alpha 1 chain
FOS FOS proto-oncogene, AP-1 transcription factor subunit
GADD45B Growth arrest and DNA damage inducible, beta
HSPA6 Heat shock 70 kDa protein 6
ITGA2 Integrin subunit alpha 2
ITGA3 Integrin subunit alpha 3
ITGB1 Integrin subunit beta 1
JUN Jun proto-oncogene, AP-1 transcription factor subunit
LAMB3 Laminin subunit beta 3
An analysis of the KEGG database indicated that most validated genes (CAPN2,
COL1A1, ITGA2, ITGA3, ITGB1, JUN and LAMB3) were associated with focal adhesions
whose regulation is involved in liver cancer cell invasion and metastasis, in association
with the dysregulation of the cytoskeletal component [78]. Interestingly, Urani and cowork-
ers also found the up-regulation of other adherent junction pathway-related genes, i.e.,
SNAI1, MET, TGFBR2, RAC and CDC42, thus confirming the facilitating role of Cd in cell
motility and metastatization processes. The other validated genes, i.e., FOS, HSPA6 and
GADD45B, were associated to the MAP kinase pathway, which is known to play a role in
hepatocarcinoma cell survival and tumor growth [79]. It is also of note that the two top
pathways of the Cd-dependent dysregulated miRNAs were related to focal adhesions and
the MAP kinase cascade.
Distinct sets of 330 and 181 genes were found impaired by the authors in [80] after
acute and chronic low concentration-CdCl2 treatment of HepG2 cells, respectively. The
majority of them were involved in detoxification and metabolic processes in the exposure
Cancers 2021, 13, 2823 10 of 18
conditions in the former, and in the regulation of various signaling pathways including the
inflammatory and insulin responses in the latter. A subset of relevant genes was further
submitted to validate their differential expression through real time-PCR (Table 6).
Table 6. PCR-validated differentially expressed genes in HepG2 hepatocarcinoma cells exposed to
0.5 µM acute or 0.1 µM chronic CdCl2 treatment [80].
Gene Protein Product Up↑ Down↓
Acute Treatment
Metallothionein 1F ↑MT1F
MT1G Metallothionein 1G ↑
MT1M Metallothionein 1M ↑
CYP3A7 Cytochrome P450 family 3 subfamily A member 7 ↓
NT5E Ecto-5′-nucleotidase ↓
SPINK1 Serine peptidase inhibitor Kazal type 1 ↓
Chronic Treatment Cytochrome P450 family 3 subfamily A member 7 ↑CYP3A7
DNAJB9 DnaJ homolog subfamily B member 9 ↑
NPNT Nephronectin ↑
ADH4 Alcohol dehydrogenase 4 ↓
EGR1 Early growth response protein 1 ↓
ID1 DNA-Binding protein inhibitor ID-1 ↓
Under acute exposure to the metal compound, as expected for cells undergoing
detoxification, the up-regulation of some members of the metallothionein gene family were
found, conceivably driven, at least in part, by the down-regulation of SPINK1 as reported
for colon cancer cells [81]. Down-regulation was also observed for ecto-5′-nucleotidase
(a.k.a. CD73), the major enzyme responsible for the enzymatic dephosphorylation of
the inflammation-promoting extracellular adenosine 5′-monophosphate nucleotide to the
immunosuppressive adenosine. Conceivably, such down-regulation might be an indicator
of a pro-inflammatory activity [82]. Interestingly, CYP3A7, whose product is involved in
drug metabolism, was either down- or up-regulated following acute or chronic exposure,
respectively, and this might be associated to the Cd cytotoxic insult in the former and
the onset of a detoxification reaction by stressed cells in the latter [83,84]. Following
chronic treatment, the up-regulation of the extracellular matrix protein nephronectin
may complement the down-regulation of NT5E and be related to the stimulation of an
inflammatory reaction, according to the evidence of protein localization in inflammatory
foci in animal models of hepatitis [85]. Other validated differentially-expressed genes
were: (i) DNAJB9, whose up-regulation may be associated with the inhibition of p53-
induced senescence leading to cell mitogenic signalization and transformation; (ii) ADH4,
whose lowered expression is linked to the stimulation of several cancer related pathways,
including ATR, FOXM1, FOXO, MTOR, NOTCH, and the p53 downstream pathway;
(iii) EGR1 coding for an anti-tumorigenic zinc-finger transcription factor; and (iv) ID1
whose down-regulation may impair the cell redox state by overproduction of ROS [86–89].
By comparison with MCF-7 breast tumor cells, 48 h-exposure to Cd also up-regulated
the expression of PRMT5 and EZH2 methyltransferase genes in HepG2 cells, albeit to a
lesser extent, as evidenced by the luciferase reporter assays, thereby confirming the impact
of the metal on the expression of the two oncogenic epigenetic regulators also in this
neoplastic cytotype [63].
5. Molecular Signatures in Lung Cancer Cells
The search for Cd exposure-associated molecular signatures has been conducted
in the following cell lines isolated from non-small cell lung carcinoma tissues: (i) H460
characterized by mutant K-ras and wild-type p53 [90,91] and its Cd-resistant derivative
RH460 established after selection via the exposure of the parental line to increasing Cd
concentrations [92]; (ii) H1299 established from a lymph node metastasis of the lung from a
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patient who had received prior radiation therapy and endowed with a homozygous partial
p53 deletion determining the lack of protein expression; and (iii) A549 characterized by
mutant K-ras, wild-type EGFR and the properties of type II alveolar epithelial cells [93].
5.1. Molecular Signatures in H460 and RH460 Cells
Kim et al. [94] studied the induction of the multidrug resistance-associated protein
1 (MRP1), coded by the ABCC1 gene, by Cd treatment in responsive H460 vs. resistant
RH460 cells. This protein is a multitasking transporter broadly involved in many aspects of
cell biology and pathology spanning from cell survival and differentiation to inflammation
and cancer [95]. The acquired Cd resistance of RH460 cells determines the absence of
Cd-induced apoptosis and autophagy, occurring in the parental line, due to the lack of
glycogen synthase kinase (GSK)-3β phosphorylation at serine residue and the consequent
intracellular relocalization of the molecule [96]. Using inhibitors and siRNAs against MRP1
and GSK-3β and overexpressing GSK-3β-HA, Kim et al. [94] revealed the role played by the
kinase in the modulation of the expression of the MRP1 molecular signature through both
transcriptional regulation and direct interaction with p-Ser GSK3αβ which intervenes in
MRP1 stabilization and intracellular redistribution. The obtained data represent a promis-
ing tool for the formulation of GSK-3β serine phosphorylation-inducing chemotherapeutics
aimed to treat multidrug resistant lung tumors.
5.2. Molecular Signatures in H1299 Cells
It is known that various metals, including Cd, interfere with the localization, folding and
function of members of the p53 protein family [97]. Within this context, Adámik et al. [98]
examined whether CdCl2 impaired the function of p63 and p73 as transcription factors.
To this purpose, the different p53 family isoforms were co-transfected with p53 family-
dependent luciferase reporter vectors (pGL3-MDM2-APP, pGL3-PGM1 and pGL3-BAX)
into p53-deficient H1299 cells. The obtained data demonstrated that the p63 and p73
transactivation of some of the p53-dependent promoters was inhibited by exposure to
20–50 mM CdCl2. This was also demonstrated in light of the data confirming the impair-
ment of the binding of the factors’ core domains to p53 consensus sequences, as revealed
by electrophoretic mobility shift assays. Thus, the sensitivity of p53 family proteins to Cd
appears to be conserved and also active in cell-based assays and, conceivably, the resulting
modulation of gene signature expression may play a central role in metal carcinogenesis.
5.3. Molecular Signatures in A549 Cells
Fujiki et al. [99] submitted A549 lung tumor cells to prolonged 20 mM CdCl2 exposure
and observed the onset of a high proliferative rate, EMT, stress fiber formation, cell locomo-
tion, and resistance to antitumor drugs. From a molecular point of view, the involvement
of Notch1 signalization in the Cd-promoted malignant progression was demonstrated,
and which was maintained for a considerable time after the removal of CdCl2 from the
culture medium. In particular, the cell treatment was associated with the up-regulation of
NOTCH1, JAG2, coding for Notch-ligand Jagged-2 protein, and MMP2, coding for matrix
metalloprotease 2, an invasion-facilitating collagenase which is a prognostic factor for
non-small cell lung cancer [100]. On the other hand, the down-regulation of NOTCH3
was a further gene signature of cell exposure to CdCl2. The cumulative results obtained
indicated that the transcriptional activity of Notch1 was stimulated by hypoxia-inducible
factor 1 (HIF-1) and that the insulin-like growth factor 1 receptor (IGF-1R)/Akt/ERK/p70
S6 kinase 1 (S6K1) cascade could cooperate with Notch1 signaling and HIF-1 following the
CdCl2 treatment of A549 cells.
6. Molecular Signatures in Nasal Septum and Nasopharyngeal Cancer Cells
Since inhalation is the primary route of Cd intake, mainly by cigarette smoking
and also by occupational exposure during working activities related to nickel–cadmium
batteries, electroplating, and paint pigments, RPMI-2650, CNE-1 and CNE-2 cell lines were
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used as an in vitro model system to examine the molecular targets of Cd-induced cancer
progression in nasal and nasopharyngeal epithelia.
6.1. Molecular Signatures in RPMI-2650 Cells
The RPMI-2650 line was isolated from the pleural effusion of a patient with an
anaplastic squamous carcinoma of the nasal septum [101]. In the light of the observed
Cd-dependent up-regulation of the intracellular ROS level and the down-regulation of
cell proliferation, Lee et al. [102] compared the mRNA expression patterns of RPMI-2650
cells grown in control conditions or exposed to 0.75 µM Cd acetate for 72 h via differ-
ential display analysis. Following a preliminary analysis of gene expression, AKR1C3,
coding for the aldo-keto reductase family 1 member C3 protein, was proven to undergo
an increase in expression, regulated by Cd at the transcription/translation level; this up-
regulation was also confirmed by Western blot analysis. This molecular signature is a
hormone activity regulator and prostaglandin F synthase is responsible for monitoring the
occupancy of hormone receptors and controlling cell proliferation and differentiation in
a hormone-independent way [103]. Based on the reported Cd-induced accumulation of
the Nrf2 transcription factor in the nucleoplasm and the restraining of the Cd-dependent
increase in the AKR1C3 protein levels by a phosphoinositide 3-kinase (PI3K) inhibitor, it
was suggested that the up-regulation of AKR1C3 may result from the augmentation of in-
tracellular ROS, at least in part through the activation of Nrf2 and the onset of PI3K-related
signalization, thereby contributing to an adaptive intracellular response to Cd cytotoxicity.
6.2. Molecular Signatures in CNE-1 and CNE-2 Cells
CNE-1 and CNE-2 cell lines were established from a well-differentiated and a poorly
differentiated nasopharyngeal squamous carcinoma, respectively, a highly invasive and
metastatic malignant tumor with unique ethnic and geographic distribution and prominent
incidences in South China and some African areas only [104,105]. With the aim to mimic
chronic low-level Cd exposure, Peng et al. [106] exposed both cell lines to a non-toxic
CdCl2 concentration (1 µM) for up to two weeks and observed the acquisition of more
proliferative and aggressive characteristics by the cells both in vitro and in vivo. Molec-
ular analyses revealed that chronic Cd treatment induced a remarkable up-regulation of
CCND1, CCNE1, MYC and JUN, thereby demonstrating the activation of Wnt/β-catenin
signaling, which is also in the parallel confirmatory data on increased β-catenin protein
immunostaining in Western blots. Further studies highlighted that chronic Cd exposure
induced the down-regulation of CSNK1A1, coding for the α isoform of casein kinase I,
via the hypermethylation of the promoter CpG islands. On the other hand, given that
this enzyme is a negative regulator of the Wnt/β-catenin pathway [107], this molecular
event might be involved, at least in part, in the exacerbation of the malignant phenotype
by neoplastic nasopharyngeal cells.
7. Conclusions
Malignant growth is a multistep process driven by accumulating genetic alterations
that progressively lead the cells to acquire novel abilities such as self-sufficiency in growth
signals, insensitivity to growth-inhibitory signals, evasion of apoptosis, limitless replicative
potential, sustained angiogenesis, tissue-invading and metastasizing attitude, oncopromot-
ing inflammatory ability, energy metabolism reprogramming and immunoevasion (the
“hallmarks of cancer” [108,109]).
Since the establishment of the HeLa cell line in 1951, human tumor cells in culture have
represented the most extensively used model system to study cancer biology providing
the wealth of information that we currently possess about the molecular, biochemical, and
genetic aspects of oncodevelopment and the modes of action of potentially anti-cancer
compounds. On the other hand, the clinical relevance and usefulness of these in vitro
models is still controversial, mostly due to the lack of interactions with other cell types
and the signaling and structural molecule-containing extracellular microenvironments
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which influence the action of drugs in vivo. Nevertheless, the growing body of data on
the molecular profiles and biological characterizations arising from established and novel
in vitro preclinical models cannot be ignored, thereby representing a highly useful resource
for the testing of scientifical hypotheses focused on the elucidation of carcinogenetic
mechanisms and the initial assessment of cancer treatments [110,111].
It is generally accepted that the knowledge of the repertoire of genes transcribed under
a given circumstance, such as the exposure to environmental pollutants, may aid in the
dissection of the mode of action of the toxicants under investigation [112]. This review
has pointed out that different neoplastic cytotypes undergo a wide range of Cd-induced
changes in their transcriptional profiles which can consequently influence protein expres-
sion, signal transduction, and cell metabolism, and ultimately tie in with the previously
listed traits of the carcinogenetic process. Figure 1 summarizes in a Venn diagram the
representation the gene signatures discussed, showing the areas of overlap between the
different cancer cell models, which is a useful procedure to select the most promising
candidates for further translation in in vivo studies.
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and the overlapping areas among the model systems.
The individuation of single or panels of novel expression markers can provide a
broader picture of the numerous and complex effects exerted by the metal and, in addition,
has potential as alternatives to traditional biomarkers for the efficient assessment of the
tumor progression stages in diverse cancers. On the other hand, descriptive epidemio-
logical studies can certainly ke advantag from detailed studies at t molecular level,
which provide new avenues for analytic research. The Cd levels in blood, urine, feces, liver,
kidney, hair, and other tissues can be easily measured and can provide an indication of
recent or total exposure to Cd, urine being the first choice medium for biomonitoring [113]
and inductively coupled plasma-mass spectrometry of hair is a powerful tool to recapit-
ulate the history of Cd exposure [114]. Thus, a combination of a chemical evaluation of
Cd with the analysis of the arrays of the so-called “biomarkers of effects”, such as the
molecular signatures, can provide a useful tool for the identification of marker genes in
risk assessment [115,116], serving in both prognostic and predictive applications for the
screening of exposed populations, as already reported in the cases of Cd-induced neuro-
and nefrotoxicity [117–119].
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